Brookdale Senior Living (BKD)
(Real Time Quote from BATS)
$6.87 USD
+0.02 (0.29%)
Updated Sep 20, 2024 11:14 AM ET
4-Sell of 5 4
C Value A Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BKD 6.87 +0.02(0.29%)
Will BKD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BKD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BKD
Why Brookdale May Not Be a Safe Bet Despite 34-Month Occupancy Growth
Brookdale (BKD) Down 7% Since Q2 Earnings Miss on Lower Interest
BKD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Brookdale Senior (BKD) Q2 Occupancy Jumps, Growth Trend Persists
Brookdale (BKD) Shows Fast-paced Momentum But Is Still a Bargain Stock
Brookdale Senior Living (BKD) Is Up 6.55% in One Week: What You Should Know
Other News for BKD
Brookdale Reports August 2024 Occupancy
Ventas price target raised by $7 at Wedbush, here's why
Brookdale Senior Living reports August weighted average occupancy up 30 points
Jefferies Sticks to Its Buy Rating for Bruker (BRKR)
Invesco Health Care Fund Q2 2024 Review